Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Hogan

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Gastroenterology|September 30, 2021
Underrepresentation of Minorities and Underreporting of Race and Ethnicity in Crohn's Disease Clinical TrialsRocio Sedano, Malcolm Hogan, Cassandra Mcdonald, et al.
Inflammatory Bowel Diseases|January 25, 2022
Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical TrialsRocio Sedano, Malcolm Hogan, Cassandra McDonald, et al.
Inflammatory Bowel Diseases|June 24, 2022
Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis TrialsRocio Sedano, Malcolm Hogan, Guangyong Zou, et al.
Dermatology and Therapy|July 31, 2023
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque PsoriasisApril W Armstrong, Sang Hee Park, Vardhaman Patel, et al.
Dermatology and Therapy|October 18, 2023
Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque PsoriasisApril W Armstrong, Sang Hee Park, Vardhaman Patel, et al.
Journal of Drugs in Dermatology : JDD|August 7, 2025
Comparative Efficacy of Deucravacitinib and Adalimumab for Scalp Psoriasis: An Indirect Treatment ComparisonVardhaman Patel, Alexa Hetzel, Sang Hee Park, et al.
Inflammatory Bowel Diseases|April 1, 2023
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysisSudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, et al.
Journal of Crohn'S & Colitis|August 5, 2022
Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis Placebo Response in ProctitisTheshani A De Silva, Lotus Alphonsus, Christopher Ma, et al.
Journal of Crohn'S & Colitis|October 22, 2022
Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn's Disease: A Systematic Review and Meta-AnalysisTanmay Sharma, Christopher Ma, Rocio Sedano, et al.
Med (New York, N.Y.)|October 5, 2024
Responsiveness of different disease activity indices in moderate-to-severe ulcerative colitisVirginia Solitano, Remo Panaccione, Bruce E Sands, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Gastroenterology|September 30, 2021
Underrepresentation of Minorities and Underreporting of Race and Ethnicity in Crohn's Disease Clinical TrialsRocio Sedano, Malcolm Hogan, Cassandra Mcdonald, et al.
Inflammatory Bowel Diseases|January 25, 2022
Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical TrialsRocio Sedano, Malcolm Hogan, Cassandra McDonald, et al.
Inflammatory Bowel Diseases|June 24, 2022
Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis TrialsRocio Sedano, Malcolm Hogan, Guangyong Zou, et al.
Dermatology and Therapy|July 31, 2023
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque PsoriasisApril W Armstrong, Sang Hee Park, Vardhaman Patel, et al.
Dermatology and Therapy|October 18, 2023
Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque PsoriasisApril W Armstrong, Sang Hee Park, Vardhaman Patel, et al.
Journal of Drugs in Dermatology : JDD|August 7, 2025
Comparative Efficacy of Deucravacitinib and Adalimumab for Scalp Psoriasis: An Indirect Treatment ComparisonVardhaman Patel, Alexa Hetzel, Sang Hee Park, et al.
Inflammatory Bowel Diseases|April 1, 2023
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysisSudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, et al.
Journal of Crohn'S & Colitis|August 5, 2022
Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis Placebo Response in ProctitisTheshani A De Silva, Lotus Alphonsus, Christopher Ma, et al.
Journal of Crohn'S & Colitis|October 22, 2022
Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn's Disease: A Systematic Review and Meta-AnalysisTanmay Sharma, Christopher Ma, Rocio Sedano, et al.
Med (New York, N.Y.)|October 5, 2024
Responsiveness of different disease activity indices in moderate-to-severe ulcerative colitisVirginia Solitano, Remo Panaccione, Bruce E Sands, et al.
Pageof 3